Extension of chronological life span in yeast by decreased TOR pathway signaling
What this study shows
Decreased TOR pathway signalling extends chronological lifespan in yeast.
At a glance
| Evidence type | M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: Yeast (S. cerevisiae)) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is. |
| Study type | 5 - Mechanistic / In Vitro |
| Model system | Yeast (S. cerevisiae) |
| Journal | Genes & development |
| Year | 2006 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1101/gad.1381406 · PMID 16418483 · Free full text (PMC1356109) |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Genetic (TOR pathway deletions) |
| Target | TOR / Sch9 |
| Model | Yeast (S. cerevisiae) |
| Effect | Decreased TOR pathway signaling extends yeast chronological lifespan |
In the Atlas
Related topics
Links in the pathway map
- Supports mTORC1 inhibits Longevity
More studies on this topic
- Disruption of the insulin/IGF-1 signaling pathway in Caenorhabditis elegans dramatically increases male longevity and enhances reproductive health late in life (2026)
- Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice (2011)
- Intermittent Administration of Rapamycin Extends the Life Span of Female C57BL/6J Mice (2016)
- Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls (2014)
Was this page useful?
Thank you. Your answer was counted anonymously.